137 related articles for article (PubMed ID: 18523732)
1. Imaging of tumor glucose utilization with positron emission tomography.
Buerkle A; Weber WA
Cancer Metastasis Rev; 2008 Dec; 27(4):545-54. PubMed ID: 18523732
[TBL] [Abstract][Full Text] [Related]
2. Revisit 18F-fluorodeoxyglucose oncology positron emission tomography: "systems molecular imaging" of glucose metabolism.
Shen B; Huang T; Sun Y; Jin Z; Li XF
Oncotarget; 2017 Jun; 8(26):43536-43542. PubMed ID: 28402949
[TBL] [Abstract][Full Text] [Related]
3. Tumor cell metabolism imaging.
Plathow C; Weber WA
J Nucl Med; 2008 Jun; 49 Suppl 2():43S-63S. PubMed ID: 18523065
[TBL] [Abstract][Full Text] [Related]
4. [PET evaluation of glucose metabolism in cancer].
Yasuda S; Fujii H; Takahashi W; Takagi S; Ide M; Shohtsu A
Gan To Kagaku Ryoho; 1999 May; 26(6):756-61. PubMed ID: 10410143
[TBL] [Abstract][Full Text] [Related]
5. [New functional imaging technique "positron emission tomography"].
Tamaki N
Hokkaido Igaku Zasshi; 1998 Mar; 73(2):101-4. PubMed ID: 9612703
[TBL] [Abstract][Full Text] [Related]
6. Positron emission tomography: clinical applications in oncology. Part 1.
Kumar R; Nadig MR; Chauhan A
Expert Rev Anticancer Ther; 2005 Dec; 5(6):1079-94. PubMed ID: 16336099
[TBL] [Abstract][Full Text] [Related]
7. [Perspective for imaging of tumor metabolism].
Kubota K; Yukihiro M; Ito K
Nihon Rinsho; 2007 Feb; 65(2):352-6. PubMed ID: 17302283
[TBL] [Abstract][Full Text] [Related]
8. [Positron emission tomography (PET) and (F-18)-fluorodeoxyglucose in (FDG) in cancerology].
Maublant J; Vuillez JP; Talbot JN; Lumbroso J; Muratet JP; Herry JY; Artus JC
Bull Cancer; 1998 Nov; 85(11):935-50. PubMed ID: 9951421
[TBL] [Abstract][Full Text] [Related]
9. Tumor-specific positron emission tomography imaging in patients: [18F] fluorodeoxyglucose and beyond.
Mankoff DA; Eary JF; Link JM; Muzi M; Rajendran JG; Spence AM; Krohn KA
Clin Cancer Res; 2007 Jun; 13(12):3460-9. PubMed ID: 17575208
[TBL] [Abstract][Full Text] [Related]
10. [Clinical usefulness of FDG-PET in oncology].
Sasaki M
Nihon Igaku Hoshasen Gakkai Zasshi; 2001 Jul; 61(8):414-20. PubMed ID: 11524817
[TBL] [Abstract][Full Text] [Related]
11. Positron emission tomography imaging in evaluation of cancer patients.
Kumar R; Bhargava P; Bozkurt MF; Zhuang H; Potenta S; Alavi A
Indian J Cancer; 2003; 40(3):87-100. PubMed ID: 14716112
[TBL] [Abstract][Full Text] [Related]
12. Clinical role of FDG PET in evaluation of cancer patients.
Kostakoglu L; Agress H; Goldsmith SJ
Radiographics; 2003; 23(2):315-40; quiz 533. PubMed ID: 12640150
[TBL] [Abstract][Full Text] [Related]
13. Differentiating Between Cancer and Inflammation: A Metabolic-Based Method for Functional Computed Tomography Imaging.
Motiei M; Dreifuss T; Betzer O; Panet H; Popovtzer A; Santana J; Abourbeh G; Mishani E; Popovtzer R
ACS Nano; 2016 Mar; 10(3):3469-77. PubMed ID: 26886076
[TBL] [Abstract][Full Text] [Related]
14. Signaling Pathways That Drive
Salas JR; Clark PM
J Nucl Med; 2022 May; 63(5):659-663. PubMed ID: 35241480
[No Abstract] [Full Text] [Related]
15. (18)F-labeled positron emission tomographic radiopharmaceuticals in oncology: an overview of radiochemistry and mechanisms of tumor localization.
Vallabhajosula S
Semin Nucl Med; 2007 Nov; 37(6):400-19. PubMed ID: 17920348
[TBL] [Abstract][Full Text] [Related]
16. Appropriate use of positron emission tomography with [(18)F]fluorodeoxyglucose for staging of oncology patients.
Tagliabue L; Del Sole A
Eur J Intern Med; 2014 Jan; 25(1):6-11. PubMed ID: 23910561
[TBL] [Abstract][Full Text] [Related]
17. PET/CT for the staging and follow-up of patients with malignancies.
Poeppel TD; Krause BJ; Heusner TA; Boy C; Bockisch A; Antoch G
Eur J Radiol; 2009 Jun; 70(3):382-92. PubMed ID: 19406595
[TBL] [Abstract][Full Text] [Related]
18. Use of PET for monitoring cancer therapy and for predicting outcome.
Weber WA
J Nucl Med; 2005 Jun; 46(6):983-95. PubMed ID: 15937310
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive Oncologic Imaging in Infants and Preschool Children With Substantially Reduced Radiation Exposure Using Combined Simultaneous ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging: A Direct Comparison to ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.
Gatidis S; Schmidt H; Gücke B; Bezrukov I; Seitz G; Ebinger M; Reimold M; Pfannenberg CA; Nikolaou K; Schwenzer NF; Schäfer JF
Invest Radiol; 2016 Jan; 51(1):7-14. PubMed ID: 26309185
[TBL] [Abstract][Full Text] [Related]
20. Potential role of FDG-PET imaging in understanding tumor-host interaction.
Gatenby RA
J Nucl Med; 1995 May; 36(5):893-9. PubMed ID: 7738670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
